BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15608417)

  • 21. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma.
    Lim KP; Cirillo N; Hassona Y; Wei W; Thurlow JK; Cheong SC; Pitiyage G; Parkinson EK; Prime SS
    J Pathol; 2011 Mar; 223(4):459-69. PubMed ID: 21294120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
    Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
    J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
    Geomela PA; Kontos CK; Yiotakis I; Scorilas A
    J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of gene expression in head and neck carcinoma using laser capture microdissection and real-time reverse transcription polymerase chain reaction.
    Malhotra PS; Malekfzali A; Bonner RF; Juhn S; Van Waes C; Chen Z
    Laryngoscope; 2004 Dec; 114(12):2123-8. PubMed ID: 15564832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative expression study of four cytokeratins and p63 in squamous cell carcinoma of the tongue: suitability for sentinel node navigation surgery using one-step nucleic acid amplification.
    Yamauchi K; Fujioka Y; Kogashiwa Y; Kohno N
    J Clin Pathol; 2011 Oct; 64(10):875-9. PubMed ID: 21705376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression.
    Koskinen WJ; Bono P; Leivo I; Vaheri A; Aaltonen LM; Joensuu H
    Radiother Oncol; 2005 Nov; 77(2):172-5. PubMed ID: 16229916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of p63 expression on survival in oral squamous cell carcinoma.
    Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
    Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma.
    Oliveira LR; Ribeiro-Silva A; Zucoloto S
    Acta Histochem; 2007; 109(5):388-96. PubMed ID: 17499344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
    Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
    J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.
    Nylander K; Coates PJ; Hall PA
    Int J Cancer; 2000 Aug; 87(3):368-72. PubMed ID: 10897041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck.
    Ibrahim SO; Vasstrand EN; Liavaag PG; Johannessen AC; Lillehaug JR
    Anticancer Res; 1997; 17(6D):4539-46. PubMed ID: 9494565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53, p63 and p73 expression in squamous cell carcinomas of the head and neck and their response to cisplatin exposure.
    Gwosdz C; Balz V; Scheckenbach K; Bier H
    Adv Otorhinolaryngol; 2005; 62():58-71. PubMed ID: 15608418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.